UBS Reiterates Buy Rating on AdaptHealth (AHCO)

August 8, 2024 9:31 AM

UBS analyst Kevin Caliendo reiterated a Buy rating and $13.00 price target on AdaptHealth (NASDAQ: AHCO).The analyst comments "AHCO's fundamentals ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found